Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033 ...
The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12 ...
Yicai Global2 天
China’s Lepu Soars on Granting US’ ArriVent Global Rights to New Cancer Drug in USD1.2 ...
In return for these rights, ArriVent will pay Lepu a one-time down payment and near-term milestone payments amounting to ...
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody ...
Exclusive global license outside of Greater Chinafor MRG007, a novel antibody drug conjugate (ADC) in development for gastrointestinal (GI) ...
Business Wire3 天
Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York
IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion ...
Antibody Drug Conjugates Market Outlook 2025-2035, with Forecasts for Payload Type, Linker ...
The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Antibody Drug Conjugates Market is set to surpass US$16 billion in 2025 ...
조선일보9 天
Celltrion targets innovative drug development with new ADC and antibody candidates
Celltrion targets innovative drug development with new ADC and antibody candidates Celltrion aims for growth by venturing ...
BioSpace13 天
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth ...
Zai Lab Gets FDA Orphan Drug Designation For ZL-1310 To Treat Small Cell Lung Cancer
Zai Lab Limited (ZLAB) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation or ODD to ZL-1310, a ...